Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-01-18
2005-01-18
Richter, Johann (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S300000, C514S105000, C514S394000, C514S361000, C548S221000, C548S305700, C548S455000, C546S152000, C546S153000, C546S113000, C544S238000, C544S058200, C544S105000, C544S279000
Reexamination Certificate
active
06844342
ABSTRACT:
The present invention concerns antiviral compounds, their methods of preparation and their compositions, and use in the treatment of viral infections. More particularly, the invention provides heterocyclic substituted 2-methylbenzimidazole derivatives for the treatment of respiratory syncytial virus infection.
REFERENCES:
patent: 3394141 (1968-07-01), Sparatore
patent: 4324794 (1982-04-01), Tidwell et al.
patent: 4939140 (1990-07-01), Larson et al.
patent: 5256668 (1993-10-01), Hsu et al.
patent: 6489338 (2002-12-01), Yu et al.
patent: 6506738 (2003-01-01), Yu et al.
patent: A-14704 (1998-12-01), None
patent: 058146 (1982-08-01), None
patent: WO 0004900 (2000-02-01), None
patent: 2000004900 (2000-02-01), None
patent: WO 0038508 (2000-07-01), None
patent: WO 0100611 (2001-01-01), None
patent: WO 0100612 (2001-01-01), None
patent: WO 0100615 (2001-01-01), None
patent: WO 0136395 (2001-05-01), None
US patent application 2002/0099208, “Heterocyclic substituted 2-methyl-Benzimidazole Antiviral Agents”, Yu et. al., Jul. 25, 2002.*
US patent application Publication 2003/0207868, Yu et. al., “Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents”, Nov. 6, 2003.
F. Pagani and F. Sparatore in Boll Chim Farm. 1965, 104, 427.
G. Paglietti et. al. in II Farmaco, Ed. Sci. 1975, 30, 505.
CA 92:128844, “Search for new antiviral agents-Part I. Synthesis of 2-phenyl-3-(alkylbenzimidazolyl)quinazolin-4-ones”, Pandey, V. K. et. al.
E. J. Dubovi, et al, Antimicrobial Agents and Chemotherapy, 19(4), pp. 649-656, 1981.
P. R. Wyde, et al, Antiviral Research, 38, pp. 31-42, 1998.
F. Pagani, et al, Boll. Chim. Farm., 104, pp. 427-431, 1965.
G. Paglietti, et al, IL. Farmaco-Ed. Sc., 30, pp. 505-511, 1975.
S. Shigeta, et al, Antiviral Chemistry & Chemotherapy, 3(3), pp. 171-177, 1992.
W. R. Roderick, et al, J. Med. Chem., 15(6), pp. 655-658, 1972.
B. Cakir, et al, Gazi Eczacilik Fak. Der., 5(1), pp. 71-77, 1988.
H. R. Howard, et al, Eur. J. Med. Chem., 27, pp. 779-789, 1992.
F. Sparatore, et al, Il Farmaco Ed. Sci., 33, pp. 901-923, 1978.
JAMA, 277(1), pp. 12-13, 1997.
E. De Clercq, Int. J. Antimicrobial Agents, 7, pp. 193-202, 1996.
R. R. Tidwell, et al, J. Med. Chem., 26, pp. 294-298, 1983.
Dubovi, E. J. et al, “Inhibition of Respiratory Syncytial Virus by Bis(5-Amidino-2-Benzimidazolyl)Methane,” VIROLOGY, 103(2), pp. 502-504, 1980.
Pandey, V. K., “Search for New Antiviral Agents. Part V. Synthesis of Some 1,2 Disubstituted Benzimidazole Derivatives,” J. Indian Chem. Soc., 58(9), pp. 893-894, 1981 (Chemical Abstracts, vol. 95 No. 28, Abstract No. 187156G, p. 645, 1981).
Civiello Rita L.
Combrink Keith D.
Gulgeze Hatice Belgin
Meanwell Nicholas
Pearc Bradley C.
Bristol--Myers Squibb Company
Duboff Samuel J.
Epperson James
Richter Johann
Robinson Binta
LandOfFree
Heterocyclic substituted 2-methyl-benzimidazole antiviral... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic substituted 2-methyl-benzimidazole antiviral..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic substituted 2-methyl-benzimidazole antiviral... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3435207